Younger Survivors Have a Lower Risk of Secondary Primary Breast Cancer
Genetic testing for women with breast cancer is important, as it may help determine the risk of developing secondary primary breast cancer.
Stay updated with breaking news from Educated Patient. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genetic testing for women with breast cancer is important, as it may help determine the risk of developing secondary primary breast cancer.
The Food and Drug Administration granted UTD1 an orphan drug designation to treat brain metastases in patients with breast cancer.
An expert discussed the importance of knowing the questions to ask a patient’s care team to navigate one’s journey, including treatment and next steps.
Recently approved by the FDA for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), Jaypirca “represents a meaningful advance” in treatment, as one expert explained.
If metastatic breast cancer no longer responds to a given therapy, finding out what targetable mutations a patient has may guide the next steps for treatment, an expert said.